Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹923.80down ₹22.20 (2.35%)BSE ₹924.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹946.00.
30 Oct: open ₹946.00, high ₹951.80, low ₹920.00
52-week range of traded prices to 30 Oct 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Next results date: the board meets on 13 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,714 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 41.79
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 35.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.54%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 56,22937.1% delivered
Jubilant Pharmova share news and announcements
1,152 announcements, routine notices left out, newest first. Page 23 of 24.
Apr 2008
22 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 53430 lacs for quarter ending on 31-MAR-2008 against Rs. 42960 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 5710 lacs for the quarter ending on 31-MAR-2008 against Rs. 6960 lacs for the quarter ending on 31-MAR-2007.22 Apr · Dividend
Board of Directors of the Company at its Meeting held on April 22, 2008 has recommended a dividend of Rs. 1.50 per equity share of Re. 1 totaling to Rs. 256.55 million, subject to approval in Annual General Meeting.22 Apr · Results
Consolidated Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 68900 lacs for quarter ending on 31-MAR-2008 against Rs. 46330 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 5820 lacs for the quarter ending on 31-MAR-2008 against Rs. 6380 lacs for the quarter ending on 31-MAR-2007.22 Apr · Results
Standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 197670 lacs for year ending on 31-MAR-2008 against Rs. 160970 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 39230 lacs for the year ending on 31-MAR-2008 against Rs. 23150 lacs for the year ending on 31-MAR-2007.22 Apr · Results
Consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 248890 lacs for year ending on 31-MAR-2008 against Rs. 180970 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 40050 lacs for the year ending on 31-MAR-2008 against Rs. 22800 lacs for the year ending on 31-MAR-2007.11 Apr · Board meeting
To inter-alia consider: (1) Audited Financial Results of the Company for the year ended March 31, 2008. (2) Recommendation of Dividend for the year ended March 31, 2008.7 Apr · Business
Press release dated April 04, 2008, titled "Jubilant To Acquire Draxis Health; All - Cash Transaction at US$6.00 Per Share". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2008
10 Mar · Allotment of Equity Shares
At a Meeting of the Special Committee of the Board of Directors held today i.e. March 10, 2008, allotment of 11,41,912 equity shares of Re.1/- each at a premium of Rs.272.0648 per share has been made to Copthall Mauritius Investments Ltd., and Swiss Finance Corp. ( Mauritius) Ltd., on conversion of a part of the Foreign Currency Convertible Bonds amounting to US $ 7.193 Million
Feb 2008
25 Feb · Allotment of Equity Shares
At a Meeting of the Special Committee of the Board of Directors held today i.e. February 25, 2008, allotment of 301,631 equity shares of Re.1/- each at a premium of Rs.272.0648 per share has been made to Copthall Mauritius Investments Ltd., on conversion of a part of the Foreign Currency Convertible Bonds amounting to US $ 1.9 Million25 Feb · Business
Press release dated February 25, 2008, titled "Jubilant announces US$ 92 million, Custom Research & Manufacturing Services contracts in CY2008; Earnings momentum seen further accelerating". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Feb · Allotment of Equity Shares
At a Meeting of the Special Committee of the Board of Directors held today i.e. February 13, 2008, allotment of 198,441 equity shares of Re.1/- each at a premium of Rs.272.0648 per share has been made to Swiss Finance Corp. (Mauritius) Ltd., on conversion of a part of the Foreign Currency Convertible Bonds amounting to US $ 1,250,000
Jan 2008
30 Jan · Allotment of shares/ others
At a Meeting of the Compensation Committee of the Board of Directors held on January 30, 2008, allotment of 40,500 equity shares of Re.1/- each at a price of Rs.201.33 per share, has been made pursuant to exercise of 8,100 options earlier granted under the "Jubilant Employees Stock Option Plan 2005". Further, 13,263 Options have been granted to eligible employees of the Company on January 30, 2008 in accordance with Jubilant Employees Stock Option Plan, 2005. Each option shall entitle the holder to subscribe to 5 equity shares of Re.1 each at a price of Rs.314.35 per share.30 Jan · Business
Press release dated January 30, 2008, titled "Q3 PAT up 40% at Rs.894 million; Net Sales grow 37% to Rs.6,416 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 49450 lacs for quarter ending on 31-DEC-2007 against Rs. 41280 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 8510 lacs for the quarter ending on 31-DEC-2007 against Rs. 6030 lacs for the quarter ending on 31-DEC-2006.30 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 64160 lacs for quarter ending on 31-DEC-2007 against Rs. 46930 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 8940 lacs for the quarter ending on 31-DEC-2007 against Rs. 6370 lacs for the quarter ending on 31-DEC-2006.9 Jan · Board meeting
Meeting of the Board of Directors, which was scheduled for January 15, 2008 inter-alia, to consider and take on record, the Unaudited Financial Results of the Company for the quarter ended December 31, 2007, has been postponed and will now be held on January 30, 2008.7 Jan · Allotment of shares
At a Meeting of the Special Committee of the Board of Directors held today i.e. January 07, 2008, allotment of 396,883 equity shares of Re.1/- each at a premium of Rs.272.0648 per share has been made to Citigroup Global Markets Mauritius Pvt. Ltd., on conversion of a part of the Foreign Currency Convertible Bonds amounting to US $ 2,500,0004 Jan · Board meeting
Meeting on 15 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Dec 2007
31 Dec · Allotment of Equity Shares
At a Meeting of the Special Committee of the Board of Directors held on December 31, 2007, allotment of 198,441 equity shares of Re.1/- each at a premium of Rs.272.0648 per share has been made to Swiss Finance Corp. (Mauritius) I Ltd., on conversion of a part of the Foreign Currency Convertible Bonds amounting to US $ 1,250,000.13 Dec · Business
Press release dated December 11, 2007, titled "Dual Recognition for Jubilant Organosys's Corporate Sustainability Program". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Dec · Business
Press release dated December 06, 2007, titled "Jubilant in drug discovery partnership with Forest Laboratories, USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
23 Nov · Allotment of Equity Shares
At a Meeting of the Special Committee of the Board of Directors held today i.e. November 23, 2007, allotment of 27,379 equity shares of Re.1, each at a premium of Rs.162.646 per share has been made to Goldman Sach Investments (Mauritius) I Ltd., on conversion of a part of the Foreign Currency Convertible Bonds amounting to US $ 100,000.
Oct 2007
30 Oct · Allotment of Equity Shares
Vide its letter dated October 26, 2007 that : "At a Meeting of the Special Committee of the Board of Directors held today i.e. October 26, 2007, allotment of 410,688 equity shares of Re. 1/- each at a premium of Rs. 162.646 per share has been made to Credit Suisse Singapore Ltd., on conversion of a part of the Foreign Currency Convertible Bonds amounting to US $ 1,500,000."16 Oct · Business
Press release dated October 16, 2007, titled "Q2 Net Profit doubles to Rs.1,100 million; Net Sales up 33% at Rs.6,183 million; H1 Net profit up 152% to Rs.2,529 million; Net Sales up 32% at Rs.11,583". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 61830 lacs for quarter ending on 30-SEP-2007 against Rs. 46590 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 11000 lacs for the quarter ending on 30-SEP-2007 against Rs. 5440 lacs for the quarter ending on 30-SEP-2006.16 Oct · Results
Standalone Results for the half year ended on 30-SEP-2007 as follows: Net Sales of Rs. 94790 lacs for half year ending on 30-SEP-2007 against Rs. 76730 lacs for the half year ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 25010 lacs for the half year ending on 30-SEP-2007 against Rs. 10160 lacs for the half year ending on 30-SEP-2006.16 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 49300 lacs for quarter ending on 30-SEP-2007 against Rs. 40860 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 11170 lacs for the quarter ending on 30-SEP-2007 against Rs. 5420 lacs for the quarter ending on 30-SEP-2006.4 Oct · Board meeting
To inter alia consider and take on record the Unaudited Financial Results of the Company for the quarter ended September 30, 2007.
Sep 2007
28 Sep · Meeting
Proceedings of the Annual General Meeting held on September 25, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Sep · Business
Press release dated September 21, 2007, titled "Jubilant Organosys Wins Golden Peacock Global Award 2007 for Excellence in Corporate Governance". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Sep · Business
Press release dated September 18, 2007, titled "Jubilant in multi million dollar long term contract with Syngenta". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Sep · Meeting
Notice of Annual General Meeting of the Company scheduled to be held on September 25, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2007
31 Aug · Meeting
Annual General Meeting of the Company will be held on September 25, 2007 and the Register of Members/Share Transfer Books of the Company will remain closed from September 19, 2007 to September 25, 2007, both days inclusive. The Dividend on equity shares, if declared at the Annual General Meeting, will be paid within 30 days of the Annual General Meeting.14 Aug · Business
Press release dated August 14, 2007, titled "Jubilant Organosys increases Pyridines/Picolines capacity to 42,000 TPA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Aug · Miscellaneous
Disclosure under Section 302 of the Companies Act, 1956, as sent to the shareholders. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
17 Jul · Business
Press release dated July 17, 2007, titled "Q1 Net Profits increase 210% to Rs.1,429 million; EPS at Rs.8.02". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 45490 lacs for quarter ending on 30-JUN-2007 against Rs. 35870 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 13840 lacs for the quarter ending on 30-JUN-2007 against Rs. 4740 lacs for the quarter ending on 30-JUN-2006.17 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 54000 lacs for quarter ending on 30-JUN-2007 against Rs. 41240 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 14290 lacs for the quarter ending on 30-JUN-2007 against Rs. 4610 lacs for the quarter ending on 30-JUN-2006.17 Jul · Allotment of shares
"At a Meeting of the Compensation Committee of the Board of Directors held today i.e. July 16, 2007, allotment of 7,375 equity shares of Re.1/- each at a price of Rs.201.33 per share, has been made pursuant to exercise of 1475 options earlier granted under the "Jubilant Employees Stock Option Plan 2005"." Further 22,273 Options have been granted to eligible employees of the Company on July 16, 2007 in accordance with Jubilant Employees Stock Option Plan, 2005. Each option shall entitle the holder to subscribe to 5 equity shares of Re.1 each at a price of Rs.309 per share.9 Jul · Board meeting
Meeting on 17 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Jun 2007
1 Jun · Business
Press release, dated June 01, 2007, titled "Jubilant Organosys completes acquisition of Hollister - Stier Laboratories". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2007
30 Apr · Business
Press release dated April 27, 2007, titled "Jubilant Organosys FY 2007 PAT up 76% Net Sales up 21% Q4 2007 PAT up 33% Net Sales up 10% Board declares 125% dividend for the year". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Apr · Allotment of shares
At a Meeting of the Compensation Committee of the Board of Directors held today i.e., April 27, 2007, allotment of 1,470 equity shares of Re.1/- each at a price of Rs.201.33 per share, has been made pursuant to exercise of 294 options earlier granted under the "Jubilant Employees Stock Option Plan 200527 Apr · Miscellaneous
Audited Financial Results under clause 20 of the Listing Agreement for the year ended March 31, 2007 as approved by the Board of Directors in their meeting held on April 27, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Apr · Dividend
Board, at its meeting held on April 27, 2007, has recommended a dividend of Rs.1.25 per equity share of Re.1/- each.25 Apr · Business
Jubliant has acquired 100% equity stake in Hollister-Stier Laboratories LLC, USA, engaged in high growth Injectable contract manufacturing and well established and stable Allergy Immunotherapy businesses. The Company has submitted to the Exchange a copy of press release, dated April 24, 2007, titled "Jubilant Organosys Acquires US based Hollister-Stier Laboratories LLC" and a presentation. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Apr · Board meeting
To inter-alia consider: (1) Audited Financial Results of the Company for the year ended March 31, 2007. (2) Recommendation of Dividend for the year ended March 31, 2007.
Mar 2007
27 Mar · E-mail ID for Investor Complaints
We already have an exclusive e-mail ID investors@jubl.com operational for last one year.20 Mar · Business
Press release, dated March 20, 2007, titled "Jubilant Organosys' signs international contracts worth US$ 60 million in Custom Research & Manufacturing Services for the year 2007". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2007
17 Jan · Business
Press release dated January 16, 2007, titled "9M FY 07- PAT up 101% Revenue up 25% YoY basis; Q3 FY 07- PAT up 74% Revenue up 11% YoY basis". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.